Ultrasound-Targeted Microbubble Destruction to Deliver siRNA Cancer Therapy

Andrew R. Carson,Charles F. McTiernan,Linda Lavery,Michelle Grata,Xiaoping Leng,Jianjun Wang,Xucai Chen,Flordeliza S. Villanueva
DOI: https://doi.org/10.1158/0008-5472.can-11-4079
IF: 11.2
2012-09-25
Cancer Research
Abstract:Microbubble contrast agents can specifically deliver nucleic acids to target tissues when exposed to ultrasound treatment parameters that mediate microbubble destruction. In this study, we evaluated whether microbubbles and ultrasound-targeted microbubble destruction (UTMD) could be used to enhance delivery of EGF receptor (EGFR)-directed siRNA to murine squamous cell carcinomas. Custom-designed microbubbles efficiently bound siRNA and mediated RNAse protection. UTMD-mediated delivery of microbubbles loaded with EGFR-directed siRNA to murine squamous carcinoma cells in vitro reduced EGFR expression and EGF-dependent growth, relative to delivery of control siRNA. Similarly, serial UTMD-mediated delivery of EGFR siRNA to squamous cell carcinoma in vivo decreased EGFR expression and increased tumor doubling time, relative to controls receiving EGFR siRNA-loaded microbubbles but not ultrasound or control siRNA-loaded microbubbles and UTMD. Taken together, our results offer a preclinical proof-of-concept for customized microbubbles and UTMD to deliver gene-targeted siRNA for cancer therapy.
oncology
What problem does this paper attempt to address?